List of Tables
Table 1. Global FAP Inhibitor Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global FAP Inhibitor Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global FAP Inhibitor Market Competitive Situation by Manufacturers in 2025
Table 4. Global FAP Inhibitor Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global FAP Inhibitor Sales Market Share by Manufacturers (2021–2026)
Table 6. Global FAP Inhibitor Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global FAP Inhibitor Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market FAP Inhibitor Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of FAP Inhibitor, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of FAP Inhibitor, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of FAP Inhibitor, Product Types and Applications
Table 12. Global Key Manufacturers of FAP Inhibitor, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global FAP Inhibitor Companies by Tier (Tier 1, Tier 2, Tier 3), based on FAP Inhibitor Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global FAP Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global FAP Inhibitor Sales by Region (K Units), 2021–2026
Table 18. Global FAP Inhibitor Sales Market Share by Region (2021–2026)
Table 19. Global FAP Inhibitor Sales by Region (K Units), 2027–2032
Table 20. Global FAP Inhibitor Sales Market Share by Region (2027–2032)
Table 21. Global FAP Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 22. Global FAP Inhibitor Revenue Market Share by Region (2021–2026)
Table 23. Global FAP Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 24. Global FAP Inhibitor Revenue Market Share by Region (2027–2032)
Table 25. North America FAP Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America FAP Inhibitor Sales by Country (K Units), 2021–2026
Table 27. North America FAP Inhibitor Sales by Country (K Units), 2027–2032
Table 28. North America FAP Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 29. North America FAP Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 30. Europe FAP Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe FAP Inhibitor Sales by Country (K Units), 2021–2026
Table 32. Europe FAP Inhibitor Sales by Country (K Units), 2027–2032
Table 33. Europe FAP Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 34. Europe FAP Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific FAP Inhibitor Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific FAP Inhibitor Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific FAP Inhibitor Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific FAP Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific FAP Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America FAP Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America FAP Inhibitor Sales by Country (K Units), 2021–2026
Table 42. Latin America FAP Inhibitor Sales by Country (K Units), 2027–2032
Table 43. Latin America FAP Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America FAP Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa FAP Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa FAP Inhibitor Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa FAP Inhibitor Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa FAP Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa FAP Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 50. Global FAP Inhibitor Sales (K Units) by Type (2021–2026)
Table 51. Global FAP Inhibitor Sales (K Units) by Type (2027–2032)
Table 52. Global FAP Inhibitor Sales Market Share by Type (2021–2026)
Table 53. Global FAP Inhibitor Sales Market Share by Type (2027–2032)
Table 54. Global FAP Inhibitor Revenue (US$ Million) by Type (2021–2026)
Table 55. Global FAP Inhibitor Revenue (US$ Million) by Type (2027–2032)
Table 56. Global FAP Inhibitor Revenue Market Share by Type (2021–2026)
Table 57. Global FAP Inhibitor Revenue Market Share by Type (2027–2032)
Table 58. Global FAP Inhibitor Price (US$/Unit) by Type (2021–2026)
Table 59. Global FAP Inhibitor Price (US$/Unit) by Type (2027–2032)
Table 60. Global FAP Inhibitor Sales (K Units) by Application (2021–2026)
Table 61. Global FAP Inhibitor Sales (K Units) by Application (2027–2032)
Table 62. Global FAP Inhibitor Sales Market Share by Application (2021–2026)
Table 63. Global FAP Inhibitor Sales Market Share by Application (2027–2032)
Table 64. Global FAP Inhibitor Revenue (US$ Million) by Application (2021–2026)
Table 65. Global FAP Inhibitor Revenue (US$ Million) by Application (2027–2032)
Table 66. Global FAP Inhibitor Revenue Market Share by Application (2021–2026)
Table 67. Global FAP Inhibitor Revenue Market Share by Application (2027–2032)
Table 68. Global FAP Inhibitor Price (US$/Unit) by Application (2021–2026)
Table 69. Global FAP Inhibitor Price (US$/Unit) by Application (2027–2032)
Table 70. SOFIE Company Information
Table 71. SOFIE Description and Business Overview
Table 72. SOFIE FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. SOFIE FAP Inhibitor Product
Table 74. SOFIE Recent Developments/Updates
Table 75. Isotopia Company Information
Table 76. Isotopia Description and Business Overview
Table 77. Isotopia FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Isotopia FAP Inhibitor Product
Table 79. Isotopia Recent Developments/Updates
Table 80. GE HealthCare Company Information
Table 81. GE HealthCare Description and Business Overview
Table 82. GE HealthCare FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. GE HealthCare FAP Inhibitor Product
Table 84. GE HealthCare Recent Developments/Updates
Table 85. Ferronova Company Information
Table 86. Ferronova Description and Business Overview
Table 87. Ferronova FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Ferronova FAP Inhibitor Product
Table 89. Ferronova Recent Developments/Updates
Table 90. Lantheus Company Information
Table 91. Lantheus Description and Business Overview
Table 92. Lantheus FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Lantheus FAP Inhibitor Product
Table 94. Lantheus Recent Developments/Updates
Table 95. Novartis AG Company Information
Table 96. Novartis AG Description and Business Overview
Table 97. Novartis AG FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Novartis AG FAP Inhibitor Product
Table 99. Novartis AG Recent Developments/Updates
Table 100. Bayer Company Information
Table 101. Bayer Description and Business Overview
Table 102. Bayer FAP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Bayer FAP Inhibitor Product
Table 104. Bayer Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. FAP Inhibitor Distributors List
Table 108. FAP Inhibitor Customers List
Table 109. FAP Inhibitor Market Trends
Table 110. FAP Inhibitor Market Drivers
Table 111. FAP Inhibitor Market Challenges
Table 112. FAP Inhibitor Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of FAP Inhibitor
Figure 2. Global FAP Inhibitor Market Value by Type (US$ Million), 2021–2032
Figure 3. Global FAP Inhibitor Market Share by Type: 2025 & 2032
Figure 4. Ga-labeled Product Picture
Figure 5. F-labeled Product Picture
Figure 6. Other Product Picture
Figure 7. Global FAP Inhibitor Market Value by Application (US$ Million), 2021–2032
Figure 8. Global FAP Inhibitor Market Share by Application: 2025 & 2032
Figure 9. Tumor Diagnosis
Figure 10. Tumor Treatment
Figure 11. Others
Figure 12. Global FAP Inhibitor Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global FAP Inhibitor Market Size (US$ Million), 2021–2032
Figure 14. Global FAP Inhibitor Sales (K Units), 2021–2032
Figure 15. Global FAP Inhibitor Average Price (US$/Unit), 2021–2032
Figure 16. FAP Inhibitor Report Years Considered
Figure 17. FAP Inhibitor Sales Share by Manufacturers in 2025
Figure 18. Global FAP Inhibitor Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global FAP Inhibitor Players: Market Share by Revenue in FAP Inhibitor in 2025
Figure 20. FAP Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global FAP Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America FAP Inhibitor Sales Market Share by Country (2021–2032)
Figure 23. North America FAP Inhibitor Revenue Market Share by Country (2021–2032)
Figure 24. United States FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe FAP Inhibitor Sales Market Share by Country (2021–2032)
Figure 27. Europe FAP Inhibitor Revenue Market Share by Country (2021–2032)
Figure 28. Germany FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific FAP Inhibitor Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific FAP Inhibitor Revenue Market Share by Region (2021–2032)
Figure 35. China FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America FAP Inhibitor Sales Market Share by Country (2021–2032)
Figure 43. Latin America FAP Inhibitor Revenue Market Share by Country (2021–2032)
Figure 44. Mexico FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa FAP Inhibitor Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa FAP Inhibitor Revenue Market Share by Country (2021–2032)
Figure 50. Turkey FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE FAP Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of FAP Inhibitor by Type (2021–2032)
Figure 54. Global Revenue Market Share of FAP Inhibitor by Type (2021–2032)
Figure 55. Global FAP Inhibitor Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of FAP Inhibitor by Application (2021–2032)
Figure 57. Global Revenue Market Share of FAP Inhibitor by Application (2021–2032)
Figure 58. Global FAP Inhibitor Price (US$/Unit) by Application (2021–2032)
Figure 59. FAP Inhibitor Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
